6,7-Dimethyl-1,4-dihydroquinoxaline-2,3-dione
95%
- Product Code: 85534
CAS:
2474-50-2
| Molecular Weight: | 190.20 g./mol | Molecular Formula: | C₁₀H₁₀N₂O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD00085437 | |
| Melting Point: | 350 °C | Boiling Point: | |
| Density: | 1.236±0.06 g/cm3(Predicted) | Storage Condition: | 2-8°C |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry due to its potential as a bioactive molecule. It has been studied for its role as an antagonist of certain receptors in the central nervous system, particularly those involved in neurodegenerative disorders. Researchers are exploring its efficacy in modulating glutamate receptors, which could make it a candidate for treating conditions like epilepsy, stroke, or Parkinson's disease. Additionally, its structural properties make it a valuable intermediate in the synthesis of more complex pharmaceutical agents. Its application extends to biochemical research, where it is used to investigate receptor-ligand interactions and signal transduction pathways.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | €102.10 |
+
-
|
| 0.250 | 10-20 days | €201.82 |
+
-
|
| 1.000 | 10-20 days | €427.39 |
+
-
|
6,7-Dimethyl-1,4-dihydroquinoxaline-2,3-dione
This compound is primarily utilized in the field of medicinal chemistry due to its potential as a bioactive molecule. It has been studied for its role as an antagonist of certain receptors in the central nervous system, particularly those involved in neurodegenerative disorders. Researchers are exploring its efficacy in modulating glutamate receptors, which could make it a candidate for treating conditions like epilepsy, stroke, or Parkinson's disease. Additionally, its structural properties make it a valuable intermediate in the synthesis of more complex pharmaceutical agents. Its application extends to biochemical research, where it is used to investigate receptor-ligand interactions and signal transduction pathways.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
€0.00
€0.00
Total :